News

Find News

Currently selected filters

  • Pritzker Institute of Biomedical Science and Engineering

CHICAGO—April 29, 2026—Illinois Institute of Technology (Illinois Tech) has been named a 2026 “Most Innovative Institution” in the inaugural 2026 Cure Innovation Index, a national benchmark assessing how effectively U.S. biomedical research institutions translate scientific discovery into real-world health impact. Illinois Tech ranked #11 among the Index’s top 20 “punching above their weight” institutions, a distinction recognizing translational research performance that exceeds expectations based on funding levels. The recognition highlights Illinois Tech’s ability to generate outsized impact through scientific excellence, entrepreneurial culture, industry engagement, and focused execution.

CHICAGO—February 16, 2022—The Intracortical Visual Prosthesis (ICVP), an implant that bypasses the retina and optic nerves to connect directly to the brain’s visual cortex, has been successfully surgically implanted in the ICVP study’s first participant at Rush University Medical Center this week. This surgery is part of a Phase I Feasibility Study of an Intracortical Visual Prosthesis for People With Blindness. The ICVP system was developed by a multi-institution team led by Philip R. Troyk—executive director of the Pritzker Institute of Biomedical Science and Engineering at Illinois Institute of Technology, professor of biomedical engineering—and represents the culmination of nearly three decades of Illinois Tech research dedicated to ultimately providing artificial sight to those with blindness due to eye disease or trauma.